Nelson EA - Search Results

1

Reciprocal effects of STAT5 and STAT3 in breast cancer.

Walker SR, Nelson EA, Zou L, Chaudhury M, Signoretti S, Richardson A, Frank DA. Walker SR, et al. Among authors: nelson ea. Mol Cancer Res. 2009 Jun;7(6):966-76. doi: 10.1158/1541-7786.MCR-08-0238. Epub 2009 Jun 2. Mol Cancer Res. 2009. PMID: 19491198

2

STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.

Walker SR, Nelson EA, Frank DA. Walker SR, et al. Among authors: nelson ea. Oncogene. 2007 Jan 11;26(2):224-33. doi: 10.1038/sj.onc.1209775. Epub 2006 Jul 3. Oncogene. 2007. PMID: 16819511

3

Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification.

Nelson EA, Walker SR, Alvarez JV, Frank DA. Nelson EA, et al. J Biol Chem. 2004 Dec 24;279(52):54724-30. doi: 10.1074/jbc.M408464200. Epub 2004 Oct 20. J Biol Chem. 2004. PMID: 15498775 Free article.

4

Identification of human STAT5-dependent gene regulatory elements based on interspecies homology.

Nelson EA, Walker SR, Li W, Liu XS, Frank DA. Nelson EA, et al. J Biol Chem. 2006 Sep 8;281(36):26216-24. doi: 10.1074/jbc.M605001200. Epub 2006 Jul 13. J Biol Chem. 2006. PMID: 16840779 Free PMC article.

5

Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3.

Nelson EA, Walker SR, Kepich A, Gashin LB, Hideshima T, Ikeda H, Chauhan D, Anderson KC, Frank DA. Nelson EA, et al. Blood. 2008 Dec 15;112(13):5095-102. doi: 10.1182/blood-2007-12-129718. Epub 2008 Sep 29. Blood. 2008. PMID: 18824601 Free PMC article.

6

Microtubule-targeted chemotherapeutic agents inhibit signal transducer and activator of transcription 3 (STAT3) signaling.

Walker SR, Chaudhury M, Nelson EA, Frank DA. Walker SR, et al. Among authors: nelson ea. Mol Pharmacol. 2010 Nov;78(5):903-8. doi: 10.1124/mol.110.066316. Epub 2010 Aug 6. Mol Pharmacol. 2010. PMID: 20693278

7

STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6.

Walker SR, Nelson EA, Yeh JE, Pinello L, Yuan GC, Frank DA. Walker SR, et al. Among authors: nelson ea. Mol Cell Biol. 2013 Aug;33(15):2879-90. doi: 10.1128/MCB.01620-12. Epub 2013 May 28. Mol Cell Biol. 2013. PMID: 23716595 Free PMC article.

8

Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2.

Liu S, Walker SR, Nelson EA, Cerulli R, Xiang M, Toniolo PA, Qi J, Stone RM, Wadleigh M, Bradner JE, Frank DA. Liu S, et al. Among authors: nelson ea. Mol Cancer Ther. 2014 May;13(5):1194-205. doi: 10.1158/1535-7163.MCT-13-0341. Epub 2014 Jan 16. Mol Cancer Ther. 2014. PMID: 24435449 Free PMC article.

9

CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.

Egusquiaguirre SP, Liu S, Tošić I, Jiang K, Walker SR, Nicolais M, Saw TY, Xiang M, Bartel K, Nelson EA, Frank DA. Egusquiaguirre SP, et al. Among authors: nelson ea. Neoplasia. 2020 Jan;22(1):47-59. doi: 10.1016/j.neo.2019.10.002. Epub 2019 Nov 22. Neoplasia. 2020. PMID: 31765941 Free PMC article.

10

The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors.

Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB, Terrell S, Klitgaard JL, Santo L, Addorio MR, Ebert BL, Griffin JD, Frank DA. Nelson EA, et al. Blood. 2011 Mar 24;117(12):3421-9. doi: 10.1182/blood-2009-11-255232. Epub 2011 Jan 13. Blood. 2011. PMID: 21233313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

580 results

Search Page

Filters